Global AI-enabled Imaging Modalities Market (2025-2031) | Forecast, Size, Share, Trends, Industry, Companies, Analysis, Value, Growth, Revenue, Outlook

AI-enabled Imaging Modalities Market Highlights

Report Name	AI-enabled Imaging Modalities Market
Forecast Period	2025-2031
Market Size	USD 14.46 billion by 2031
CAGR	27.1%
Growing Sector	Retail & E-commerce

Topics Covered in the AI-enabled Imaging Modalities Market Report

The AI-enabled Imaging Modalities Market report thoroughly covers the market by Product, Therapeutic Application, Modality, Workflow and Key Regions including the Asia Pacific, Latin America, Middle East, Europe, North America and Africa. The report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high-growth areas, and market drivers to help stakeholders align their strategies with current and future market dynamics.

AI-enabled Imaging Modalities Market Size & Analysis  

The market for AI-enabled imaging modalities is expected to grow at a robust CAGR of 27.1% from its estimated USD 1.67 billion in 2025 to USD 14.46 billion by 2031. AI technological breakthroughs, which keep improving healthcare imaging's diagnostic accuracy and efficiency, are the main driver of this remarkable increase. The market is growing as a result of the growing need for accurate diagnostics and the incorporation of AI technologies into imaging processes.

AI-enabled Imaging Modalities Market Synopsis

It is anticipated that the market for AI-enabled imaging modalities would expand significantly due to the quick use of AI in medical imaging. As the need for precision diagnostics grows, these developments are improving diagnostic efficiency and accuracy. AI-enabled imaging workflows are transforming the way medical professionals identify and treat illnesses. Areas like Asia-Pacific, which is witnessing substantial expenditures in healthcare and technology, and North America, which has a robust infrastructure, are becoming important contributors to this dynamic market environment.

According to 6Wresearch, the AI-enabled Imaging Modalities Market is anticipated to grow at a CAGR of 27.1% during the forecast period 2025-2031. The AI-enabled Imaging Modalities market growth is driven by advancements in AI technologies that improve diagnostic accuracy and expedite imaging procedures. Detecting and treating complicated diseases requires the integration of AI, as evidenced by the growing demand for precision diagnostics across healthcare industries. Furthermore, healthcare providers' operational efficiency is increasing due to the broad adoption of AI-driven solutions, which makes faster and more accurate diagnosis possible. Strong expenditures in healthcare infrastructure and technology innovation, particularly in North America and Asia-Pacific, further propel market expansion.

Although the market for AI-enabled imaging modalities has great potential, there are a number of obstacles that could prevent the widespread adoption of AI in clinical imaging. These include high implementation costs and the financial burden of integrating AI systems into existing healthcare infrastructures, data privacy concerns because handling sensitive patient data necessitates strict security measures, and the difficulty of navigating complex global regulatory frameworks and ensuring compliance with changing health laws.

AI-enabled Imaging Modalities Market Trends

Growing use of AI in healthcare imaging is driving dynamic trends in the market for AI-enabled imaging modalities. While AI integration with cutting-edge imaging technology like MRI and CT scans is revolutionizing imaging workflows, machine learning is improving diagnostic accuracy. AI is being used in predictive analytics and personalized medicine to provide more individualized patient care. AI-enabled imaging is becoming more widely available because to cloud-based solutions and telemedicine, especially in rural areas. This changing market is also being shaped by regional developments, such as the strong healthcare system in North America and the technological investments in Asia-Pacific.

Investment Opportunities in the AI-enabled Imaging Modalities Market

There are several profitable investment prospects in the AI-enabled imaging modalities market, especially when developing cutting-edge AI algorithms to improve diagnostic accuracy. There is potential for expansion in the integration of AI with cutting-edge imaging technologies, such as MRI and CT. Access to AI-enabled imaging is growing thanks to investments in telemedicine and cloud-based solutions, particularly in rural areas. Precision diagnostics demand is driving unrealized potential in emerging nations with developing healthcare infrastructure. Innovative developments and market expansion are being facilitated by government programs encouraging the adoption of AI as well as strategic partnerships between tech companies and healthcare providers.

Leading Players in the AI-enabled Imaging Modalities Market

The leading companies in the AI-enabled Imaging Modalities Market are IBM Watson Health, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems. With the development of advanced AI-driven imaging technologies that improve diagnostic efficiency and accuracy, these industry leaders are spearheading innovation. They are expanding the possibilities for integrating AI into sophisticated imaging systems like MRI and CT through strategic alliances and partnerships. Their priorities include growing their business in developing nations, addressing the rising need for accurate diagnostics, and enhancing access to healthcare. Together, their work is influencing how AI will develop in medical imaging in the future.

Government Regulations in the AI-enabled Imaging Modalities Market

Government rules that guarantee safety, effectiveness, and moral applications have a major impact on the AI-enabled imaging modalities market. The FDA supports innovation while ensuring oversight through its Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan, which addresses the development and approval of AI-driven medical solutions in the United States. To protect sensitive patient data, the General Data Protection Regulation (GDPR) of the European Union requires stringent data privacy safeguards. As for the EU's Medical Device Regulation (MDR), which sets strict requirements for approving AI-integrated products, it promotes technological improvements and compliance throughout the healthcare industry.

Future Insights of the AI-enabled Imaging Modalities Market

As AI algorithms are expected to improve diagnosis accuracy and smoothly integrate with new technologies like 3D imaging and augmented reality, the market for AI-enabled imaging modalities appears to have a bright future. In order to enable more individualized therapies, AI is anticipated to play an even bigger role in predictive analytics and customized medicine. Increased use of remote diagnostics and telemedicine will increase access to high-quality medical treatment. Ongoing R&D expenditures will spur innovation, and the use of AI in underprivileged areas could revolutionize access to and delivery of healthcare globally in previously unheard-of ways.

Market Segmentation Analysis

The report offers a comprehensive study of the following market segments and their leading categories:

Subscription software licenses are anticipated to dominate the Market – By Product

According to Ashutosh, Senior Research Analyst at 6Wresearch,  There are two segments in the market for AI-enabled imaging modalities: software and hardware. There are three different types of software licenses: fee-per-case, subscription, and perpetual. Subscription software licenses are anticipated to predominate among them because of their affordability and scalability, which allow for broad adoption by healthcare providers. Improvements in imaging technologies are driving further growth in hardware, but software's adaptability and integration potential are probably going to dominate the market.

Oncology is anticipated to dominate the Market – By Therapeutic Application

Orthopedics, cardiology, pulmonary, cancer, and other fields are among the key therapeutic uses. Oncology is anticipated to dominate because of the increasing incidence of cancer and the need for accurate diagnostic instruments. Oncology relies heavily on AI-powered imaging since it supports individualized treatment programs and aids in early tumor detection. The growing number of occurrences of linked disorders worldwide is also driving interest in cardiology and respiratory imaging.

Ultrasound is expected to dominate the Market – By Modality

Modalities including mammography, x-rays, ultrasounds, and others are used to divide the market. Ultrasound is expected to be the most popular of these because of its many uses, non-invasive nature, and continuous integration with AI for improved image accuracy. Although mammography and x-rays are still useful for some diagnostic purposes, ultrasonography is a leader in the modality category due to its safety and adaptability.

Image Analytics is expected to dominate the Market – By Workflow

Image acquisition, image analytics, detection, reporting & communication, diagnostic & treatment decision reporting, and other processes are all part of AI-enabled imaging workflows. Image analytics is poised to take center stage due to the increasing dependence on AI for data interpretation and analysis. This shortens turnaround times while increasing diagnostic accuracy. Workflows for detection and diagnosis are also growing as AI-driven decision-making technologies are further included into healthcare systems.

North America is expected to lead the Market – By Regions

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa comprise the market's geographic segments. North America's strong healthcare system, large R&D expenditures, and widespread use of AI technology are projected to keep it at the top of the market. Improving healthcare systems and the growing emphasis on implementing AI in diagnostics, particularly in nations like China and India, are also making the Asia Pacific region a major growth sector.

Key Attractiveness of the Report

 

• 10 Years of Market Numbers.
• Historical Data Starting from 2021 to 2024.
• Base Year: 2024
• Forecast Data until 2031.
• Key Performance Indicators Impacting the Market.
• Major Upcoming Developments and Projects.

Key Highlights of the Report:

• Global AI-enabled Imaging Modalities Market Overview
• Global AI-enabled Imaging Modalities Market Outlook
• Global AI-enabled Imaging Modalities Market Forecast
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues for the Period 2021-2031
• Global AI-enabled Imaging Modalities Market Size and Global AI-enabled Imaging Modalities Market Forecast of Revenues, Until 2031
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues, by Therapeutic Application, for the Period 2021-2031
• Market Size & Forecast of Global AI-enabled Imaging Modalities Market Revenues, by Therapeutic Application, Until 2031
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues, by Modality, for the Period 2021-2031
• Market Size & Forecast of Global AI-enabled Imaging Modalities Market Revenues, by Modality, Until 2031
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues, by Product, for the Period 2021-2031
• Market Size & Forecast of Global AI-enabled Imaging Modalities Market Revenues, by Product, Until 2031
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues, by Workflow, for the Period 2021-2031
• Market Size & Forecast of Global AI-enabled Imaging Modalities Market Revenues, by Workflow, Until 2031
• Historical Data of Global AI-enabled Imaging Modalities Market Revenues, by Regions, for the Period 2021-2031
• Market Size & Forecast of Global AI-enabled Imaging Modalities Market Revenues, by Regions, Until 2031
• Historical Data of Asia Pacific AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Asia Pacific AI-enabled Imaging Modalities Market Revenues, Until 2031
• Historical Data of Latin America AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Latin America AI-enabled Imaging Modalities Market Revenues, Until 2031
• Historical Data of Europe AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Europe AI-enabled Imaging Modalities Market Revenues, Until 2031
• Historical Data of Middle East AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Middle East AI-enabled Imaging Modalities Market Revenues, Until 2031
• Historical Data of North America AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of North America AI-enabled Imaging Modalities Market Revenues, Until 2031
• Historical Data of Africa AI-enabled Imaging Modalities Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Africa AI-enabled Imaging Modalities Market Revenues, Until 2031
• Market Drivers and Restraints
• Global AI-enabled Imaging Modalities Market Trends and End users Life Cycle
• Porter’s Five Force Analysis
• Market Opportunity Assessment
• Global AI-enabled Imaging Modalities Market Share, By Players
• Global AI-enabled Imaging Modalities Market Share, By Regions
• Global AI-enabled Imaging Modalities Market Overview on Competitive Benchmarking
• Company Profiles

Markets Covered

The AI-enabled Imaging Modalities Market report provides a detailed analysis of the following market segments:

By Product:

• Software
• Perpetual Software License
• Subscription Software License
• Fee-per Case Software License
• Hardware

By Workflow:

• Image Acquisition
• Image Analytics
• Detection
• Reporting & Communication
• Diagnosis & Treatment Decision Report
• Others

By Therapeutic Application:

• Cardiology
• Oncology
• Respiratory
• Orthopedics
• Others

By Modality:

• Mammography
• X-ray
• Ultrasound
• Others

By Regions